Log in
Enquire now
Arch Oncology

Arch Oncology

Antibody Therapies

OverviewStructured DataIssuesContributors

Contents

archoncology.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Cancer immunotherapy
Cancer immunotherapy
Immunotherapy
Immunotherapy
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Medicine
Medicine
Internal medicine
Internal medicine
Biopharmaceutical
Biopharmaceutical
Cancer
Cancer
...
Location
Brisbane, California
Brisbane, California
CEO
‌
Laurence Blumberg
Pitchbook URL
pitchbook.com/profiles.../56258-65
Number of Employees (Ranges)
11 – 50
Email Address
Full Address
2000 Sierra Point Pkwy, Brisbane, California 94005, US
Investors
LightChain
LightChain
Roche Venture Fund
Roche Venture Fund
RiverVest Venture Partners
RiverVest Venture Partners
Missouri Technology Corporation
Missouri Technology Corporation
0
Rodger O. Riney
Rodger O. Riney
Total Funding Amount (USD)
260,000,000
Latest Funding Round Date
May 24, 2021
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Active
Invested in
Roche Venture Fund
Roche Venture Fund
Latest Funding Round Amount (USD)
105,000,000
Public/Private
Private
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Arch Oncology

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.